• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . Post-acute COVID-19 condition in Saudi Arabia: A national representative study

tetano

Editor, Senior Moderator
J Infect Public Health


. 2022 Mar 25;15(5):526-532.
doi: 10.1016/j.jiph.2022.03.013. Online ahead of print.
Post-acute COVID-19 condition in Saudi Arabia: A national representative study


Faten A AlRadini[SUP] 1 [/SUP], Fahad Alamri[SUP] 2 [/SUP], Muna S Aljahany[SUP] 3 [/SUP], Yasir Almuzaini[SUP] 4 [/SUP], Yousef Alsofayan[SUP] 5 [/SUP], Anas Khan[SUP] 6 [/SUP], Nada Albogami[SUP] 7 [/SUP], Maha Abdulrahim[SUP] 8 [/SUP], Alanoud Almogbil[SUP] 9 [/SUP], Ahmed Alahmari[SUP] 10 [/SUP]



Affiliations

Abstract

Background: Many survivors of COVID-19 have developed symptoms and diseases similar to those observed after severe acute respiratory syndrome (SARS). Therefore, this study aimed to characterize the symptoms that appear after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been eradicated and to determine their relationship with COVID-19 severity.
Methods: This multicenter, retrospective cross-sectional study was conducted in all eligible confirmed cases of SARS-CoV-2 infection from Saudi Arabia. Study participants were randomly selected using computerized random sampling from a population of 314,821 patients. Descriptive statistics were used to describe baseline demographic data and clinical characteristics. Categorical variables were presented as counts and percentages, while continuous variables were presented as means and standard deviations.
Results: Approximately 70% of patients were found to have five or fewer symptoms simultaneously. Late symptoms (in the ongoing symptomatic COVID-19) occurred in 225 (22·5%) patients with the most common late symptoms being loss of smell, loss of taste, fatigue, shortness of breath, and cough (52·4%, 31·1%, 11·5%, 10·2%, and 8·9% of patients with late symptoms, respectively). We also found that the presence of acute symptoms of COVID-19 and admission to the hospital were significant independent predictors of the post-COVID-19 condition.
Conclusion: Saudi patients with COVID-19 develop a wide range of symptoms, similar to those observed and reported in other countries. The loss of smell, the loss of taste, shortness of breath, and fatigue were the main persistent symptoms. Regular follow-up of COVID-19 survivors is highly recommended to minimize the burden of the post-acute COVID-19 condition and improve the quality of life of patients.

Keywords: Late symptoms; Persistent symptoms; Post-acute COVID-19 condition; SARS-CoV-2.
 
Back
Top Bottom